Siegfried Holding AG/Fr. SFZN
1D1W1MYTD1Y5YMAX
Capital at risk
About Siegfried Holding AG
Siegfried Holding AG operates in the pharmaceuticals and healthcare industry, specializing in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company provides comprehensive contract development and manufacturing services to the pharmaceutical industry, including product development, manufacturing, and packaging. Founded in 1873, Siegfried has a long-established history and is headquartered in Zofingen, Switzerland. Its strategic positioning lies in its global manufacturing network, with facilities across Europe, North America, and Asia, which allows it to serve a diverse international client base effectively. The company's competitive strength is enhanced by its integrated service offerings and commitment to quality and innovation in pharmaceutical production.
- Ticker
- Fr. SFZN
- Sector
- Health
- Primary listing
- XSWX
- Employees
- 4,454
- Headquarters
- Zofingen, Switzerland
- Website
- www.siegfried.ch
SFZN Metrics
BasicAdvanced
CHF 3.1B
18.16
CHF 3.90
0.81
CHF 0.40
0.56%
Price and volume
Market cap
CHF 3.1B
Beta
0.81
52-week high
CHF 101.60
52-week low
CHF 65.05
Average daily volume
120K
Dividend rate
CHF 0.40
Financial strength
Current ratio
3.453
Quick ratio
1.359
Long term debt to equity
0.931
Total debt to equity
0.931
Dividend payout ratio (TTM)
10.23%
Interest coverage (TTM)
24.15%
Profitability
EBITDA (TTM)
316.528
Gross margin (TTM)
26.97%
Net profit margin (TTM)
12.77%
Operating margin (TTM)
16.71%
Effective tax rate (TTM)
19.29%
Revenue per employee (TTM)
CHF 300,000
Management effectiveness
Return on assets (TTM)
6.38%
Return on equity (TTM)
16.96%
Valuation
Price to earnings (TTM)
18.156
Price to revenue (TTM)
2.318
Price to book
3.12
Price to tangible book (TTM)
3.34
Price to free cash flow (TTM)
-108.226
Free cash flow yield (TTM)
-0.92%
Free cash flow per share (TTM)
-0.654
Dividend yield (TTM)
0.56%
Growth
Revenue change (TTM)
3.64%
Earnings per share change (TTM)
11.22%
3-year revenue growth (CAGR)
2.38%
10-year revenue growth (CAGR)
7.79%
3-year earnings per share growth (CAGR)
3.84%
10-year earnings per share growth (CAGR)
16.69%
3-year dividend per share growth (CAGR)
5.57%
10-year dividend per share growth (CAGR)
8.31%
Upcoming events
No upcoming events
Funds containing SFZN
AllUSDEURGBP
Fund name | Fund size | Fr. SFZN weighting |
|---|---|---|
iShares Healthcare Innovation$HEAL | $1.4B | 0.37% |
iShares Healthcare Innovation€2B78 | €1.2B | 0.37% |
iShares Healthcare Innovation£DRDR | £1B | 0.37% |
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.22% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.22% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.